{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T04:24:42Z","timestamp":1780374282263,"version":"3.54.1"},"reference-count":59,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","amjmedsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of the Medical Sciences"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.amjms.2017.04.002","type":"journal-article","created":{"date-parts":[[2017,4,6]],"date-time":"2017-04-06T07:01:30Z","timestamp":1491462090000},"page":"486-492","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":74,"title":["Eosinophilic Myocarditis"],"prefix":"10.1016","volume":"354","author":[{"given":"Christopher C.","family":"Cheung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maggie","family":"Constantine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Ahmadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn","family":"Shiau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke Y.C.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.amjms.2017.04.002_bib1","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1111\/j.1365-2141.2006.06038.x","article-title":"Eosinophilia: secondary, clonal and idiopathic","volume":"133","author":"Tefferi","year":"2006","journal-title":"Br J Haematol"},{"issue":"2","key":"10.1016\/j.amjms.2017.04.002_bib2","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1159\/000445215","article-title":"A player and coordinator: the versatile roles of eosinophils in the immune system","volume":"43","author":"Long","year":"2016","journal-title":"Transfus Med Hemother"},{"issue":"3","key":"10.1016\/j.amjms.2017.04.002_bib3","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/ajh.23664","article-title":"World Health Organization-defined eosinophilic disorders: 2014 update on diagnosis, risk stratification, and management","volume":"89","author":"Gotlib","year":"2014","journal-title":"Am J Hematol"},{"issue":"6","key":"10.1016\/j.amjms.2017.04.002_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2009.09.022","article-title":"Hypereosinophilic syndrome: a multicenter, retrospective analysis of clinical characteristics and response to therapy","volume":"124","author":"Ogbogu","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.amjms.2017.04.002_bib5","first-page":"817","article-title":"Endocarditis parietalis fibroplastica mit blut-eosinphilie, ein eigenartiges krankheitshild","volume":"66","author":"Loeffler","year":"1936","journal-title":"Schweiz Med Wochenschr"},{"issue":"10","key":"10.1016\/j.amjms.2017.04.002_bib6","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1182\/blood.V83.10.2759.2759","article-title":"The idiopathic hypereosinophilic syndrome","volume":"83","author":"Weller","year":"1994","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.amjms.2017.04.002_bib7","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.clinbiochem.2003.08.004","article-title":"Significance of elevated cobalamin (vitamin B12) levels in blood","volume":"36","author":"Ermens","year":"2003","journal-title":"Clin Biochem"},{"issue":"3","key":"10.1016\/j.amjms.2017.04.002_bib8","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.iac.2007.07.001","article-title":"Cardiovascular manifestations of hypereosinophilic syndromes","volume":"27","author":"Ogbogu","year":"2007","journal-title":"Immunol Allergy Clin North Am"},{"issue":"1","key":"10.1016\/j.amjms.2017.04.002_bib9","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1002\/art.37721","article-title":"Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): clinical characteristics and long-term followup of the 383 patients enrolled in the French Vasculitis Study Group cohort","volume":"65","author":"Comarmond","year":"2013","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.amjms.2017.04.002_bib10","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1136\/annrheumdis-2012-201531","article-title":"A vasculitis centre based management strategy leads to improved outcome in eosinophilic granulomatosis and polyangiitis (Churg-Strauss, EGPA): monocentric experiences in 150 patients","volume":"72","author":"Moosig","year":"2013","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"10.1016\/j.amjms.2017.04.002_bib11","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1002\/ajh.24196","article-title":"World Health Organization-defined eosinophilic disorders: 2015 update on diagnosis, risk stratification, and management","volume":"90","author":"Gotlib","year":"2015","journal-title":"Am J Hematol"},{"issue":"10","key":"10.1016\/j.amjms.2017.04.002_bib12","doi-asserted-by":"crossref","first-page":"3038","DOI":"10.1182\/blood-2004-03-0787","article-title":"FIP1L1-PDGFRA fusion: prevalence and clinicopathologic correlates in 89 consecutive patients with moderate to severe eosinophilia","volume":"104","author":"Pardanani","year":"2004","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.amjms.2017.04.002_bib13","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.leukres.2005.11.011","article-title":"FIP1L1-PDGFRA in eosinophilic disorders: prevalence in routine clinical practice, long-term experience with imatinib therapy, and a critical review of the literature","volume":"30","author":"Pardanani","year":"2006","journal-title":"Leuk Res"},{"issue":"4","key":"10.1016\/j.amjms.2017.04.002_bib14","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.acvd.2015.01.006","article-title":"Eosinophilic cardiac disease: molecular, clinical and imaging aspects","volume":"108","author":"Seguela","year":"2015","journal-title":"Arch Cardiovasc Dis"},{"issue":"22","key":"10.1016\/j.amjms.2017.04.002_bib15","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1056\/NEJM199011293232207","article-title":"Cardiac localization of eosinophil-granule major basic protein in acute necrotizing myocarditis","volume":"323","author":"deMello","year":"1990","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.amjms.2017.04.002_bib16","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.4049\/jimmunol.157.3.1219","article-title":"Eosinophil granule proteins activate human heart mast cells","volume":"157","author":"Patella","year":"1996","journal-title":"J Immunol"},{"issue":"4","key":"10.1016\/j.amjms.2017.04.002_bib17","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1093\/rheumatology\/kes420","article-title":"A fatal attraction: eosinophils and the heart","volume":"52","author":"Moosig","year":"2013","journal-title":"Rheumatology (Oxford, England)"},{"issue":"4","key":"10.1016\/j.amjms.2017.04.002_bib18","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1084\/jem.182.4.1169","article-title":"Cooperation between interleukin-5 and the chemokine eotaxin to induce eosinophil accumulation in vivo","volume":"182","author":"Collins","year":"1995","journal-title":"J Exp Med"},{"issue":"11","key":"10.1016\/j.amjms.2017.04.002_bib19","doi-asserted-by":"crossref","first-page":"6273","DOI":"10.1073\/pnas.95.11.6273","article-title":"Eotaxin is required for the baseline level of tissue eosinophils","volume":"95","author":"Matthews","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"10.1016\/j.amjms.2017.04.002_bib20","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1002\/eji.201646557","article-title":"Macrophages and cardiac fibroblasts are the main producers of eotaxins and regulate eosinophil trafficking to the heart","volume":"46","author":"Diny","year":"2016","journal-title":"Eur J Immunol"},{"issue":"11","key":"10.1016\/j.amjms.2017.04.002_bib21","doi-asserted-by":"crossref","first-page":"e111862","DOI":"10.1371\/journal.pone.0111862","article-title":"Enhanced tissue factor expression by blood eosinophils from patients with hypereosinophilia: a possible link with thrombosis","volume":"9","author":"Cugno","year":"2014","journal-title":"PloS One"},{"issue":"4","key":"10.1016\/j.amjms.2017.04.002_bib22","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1172\/JCI116382","article-title":"Eosinophil cationic granule proteins impair thrombomodulin function. A potential mechanism for thromboembolism in hypereosinophilic heart disease","volume":"91","author":"Slungaard","year":"1993","journal-title":"J Clin Invest"},{"issue":"7","key":"10.1016\/j.amjms.2017.04.002_bib23","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0025-6196(11)63564-7","article-title":"Eosinophilic myocarditis manifesting as myocardial infarction: early diagnosis and successful treatment","volume":"72","author":"Galiuto","year":"1997","journal-title":"Mayo Clin Proc"},{"issue":"1","key":"10.1016\/j.amjms.2017.04.002_bib24","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/1471-2261-13-75","article-title":"Hypereosinophilic syndrome masquerading as a myocardial infarction causing decompensated heart failure","volume":"13","author":"Lim","year":"2013","journal-title":"BMC Cardiovasc Disord"},{"issue":"14","key":"10.1016\/j.amjms.2017.04.002_bib25","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/S0828-282X(06)70965-5","article-title":"Eosinophilic myocarditis: case series and review of literature","volume":"22","author":"Al Ali","year":"2006","journal-title":"Can J Cardiol"},{"issue":"3","key":"10.1016\/j.amjms.2017.04.002_bib26","doi-asserted-by":"crossref","first-page":"201","DOI":"10.7326\/0003-4819-115-3-201","article-title":"Acute necrotizing eosinophilic myocarditis as a manifestation of severe hypersensitivity myocarditis. Antemortem diagnosis and successful treatment","volume":"115","author":"Getz","year":"1991","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.amjms.2017.04.002_bib27","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1161\/01.CIR.0000135586.94417.3C","article-title":"Images in cardiovascular medicine. Infiltrative eosinophilic myocarditis diagnosed and localized by cardiac magnetic resonance imaging","volume":"110","author":"Chun","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.amjms.2017.04.002_bib28","doi-asserted-by":"crossref","first-page":"2829583","DOI":"10.1155\/2016\/2829583","article-title":"Current diagnostic and therapeutic aspects of eosinophilic myocarditis","volume":"2016","author":"Kuchynka","year":"2016","journal-title":"BioMed Res Int"},{"issue":"4","key":"10.1016\/j.amjms.2017.04.002_bib29","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1093\/rheumatology\/kes155","article-title":"Churg-Strauss syndrome cardiac involvement evaluated by cardiac magnetic resonance imaging and positron-emission tomography: a prospective study on 20 patients","volume":"52","author":"Marmursztejn","year":"2013","journal-title":"Rheumatology (Oxford, England)"},{"issue":"8","key":"10.1016\/j.amjms.2017.04.002_bib30","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1007\/s00059-012-3701-2","article-title":"Eosinophilic myocarditis","volume":"37","author":"Baandrup","year":"2012","journal-title":"Herz"},{"issue":"24","key":"10.1016\/j.amjms.2017.04.002_bib31","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1161\/CIRCULATIONAHA.115.021178","article-title":"Tropical endomyocardial fibrosis: natural history, challenges, and perspectives","volume":"133","author":"Grimaldi","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.amjms.2017.04.002_bib32","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Swerdlow","year":"2008"},{"issue":"3","key":"10.1016\/j.amjms.2017.04.002_bib33","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.jaci.2012.07.024","article-title":"Workshop report from the National Institutes of Health Taskforce on the Research Needs of Eosinophil-Associated Diseases (TREAD)","volume":"130","author":"Bochner","year":"2012","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.amjms.2017.04.002_bib34","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/j.jaci.2006.02.042","article-title":"Approaches to the treatment of hypereosinophilic syndromes: a workshop summary report","volume":"117","author":"Klion","year":"2006","journal-title":"J Allergy Clin Immunol"},{"issue":"9","key":"10.1016\/j.amjms.2017.04.002_bib35","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1182\/blood-2014-11-551614","article-title":"How I treat hypereosinophilic syndromes","volume":"126","author":"Klion","year":"2015","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.amjms.2017.04.002_bib36","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/ccr3.201","article-title":"Polyclonal hyperviscosity syndrome in IgG4-related disease and associated conditions","volume":"3","author":"Chen","year":"2015","journal-title":"Clin Case Rep"},{"key":"10.1016\/j.amjms.2017.04.002_bib37","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1146\/annurev-pathol-012513-104708","article-title":"IgG4-related disease","volume":"9","author":"Mahajan","year":"2014","journal-title":"Annu Rev Pathol"},{"issue":"4","key":"10.1016\/j.amjms.2017.04.002_bib38","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/ejh.12842","article-title":"IgG4-related disease and lymphocyte-variant hypereosinophilic syndrome: a comparative case series","volume":"98","author":"Carruthers","year":"2017","journal-title":"Eur J Haematol"},{"issue":"1","key":"10.1016\/j.amjms.2017.04.002_bib39","first-page":"26","article-title":"Hallway consult: does this patient have IgG4-related disease?","volume":"25","author":"Chen","year":"2015","journal-title":"Can Rheumatol Assoc J"},{"issue":"10","key":"10.1016\/j.amjms.2017.04.002_bib40","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1056\/NEJM200103083441005","article-title":"High serum IgG4 concentrations in patients with sclerosing pancreatitis","volume":"344","author":"Hamano","year":"2001","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.amjms.2017.04.002_bib41","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1007\/s00535-003-1175-y","article-title":"A new clinicopathological entity of IgG4-related autoimmune disease","volume":"38","author":"Kamisawa","year":"2003","journal-title":"J Gastroenterol"},{"issue":"3","key":"10.1016\/j.amjms.2017.04.002_bib42","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/ejh.12059","article-title":"IgG4-related disease with hypergammaglobulinemic hyperviscosity and retinopathy","volume":"90","author":"Wong","year":"2013","journal-title":"Eur J Haematol"},{"issue":"1","key":"10.1016\/j.amjms.2017.04.002_bib43","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1136\/annrheumdis-2013-204907","article-title":"The diagnostic utility of serum IgG4 concentrations in IgG4-related disease","volume":"74","author":"Carruthers","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.amjms.2017.04.002_bib44","doi-asserted-by":"crossref","first-page":"230","DOI":"10.14797\/mdcj-9-4-230","article-title":"IgG4 related cardiac disease","volume":"9","author":"Carbajal","year":"2013","journal-title":"Methodist DeBakey Cardiovasc J"},{"issue":"15","key":"10.1016\/j.amjms.2017.04.002_bib45","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1056\/NEJM199910073411503","article-title":"Abnormal clones of T cells producing interleukin-5 in idiopathic eosinophilia","volume":"341","author":"Simon","year":"1999","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.amjms.2017.04.002_bib46","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.iac.2007.07.002","article-title":"Lymphocytic variant hypereosinophilic syndromes","volume":"27","author":"Roufosse","year":"2007","journal-title":"Immunol Allergy Clin North Am"},{"issue":"8","key":"10.1016\/j.amjms.2017.04.002_bib47","first-page":"1086","article-title":"CD3-CD4+ lymphoid variant of hypereosinophilic syndrome: nodal and extranodal histopathological and immunophenotypic features of a peripheral indolent clonal T-cell lymphoproliferative disorder","volume":"100","author":"Lefevre","year":"2015","journal-title":"Haematologica"},{"issue":"5","key":"10.1016\/j.amjms.2017.04.002_bib48","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/j.1365-2141.2004.05206.x","article-title":"Alemtuzumab therapy for refractory idiopathic hypereosinophilic syndrome with abnormal T cells: a case report","volume":"127","author":"Pitini","year":"2004","journal-title":"Br J Haematol"},{"issue":"2","key":"10.1016\/j.amjms.2017.04.002_bib49","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1016\/j.ijcard.2008.11.018","article-title":"Atypical cardiac manifestation of hypereosinophilic syndrome and reversible cardiotoxicity to imatinib","volume":"139","author":"Garcia-Alvarez","year":"2010","journal-title":"Int J Cardiol"},{"issue":"9","key":"10.1016\/j.amjms.2017.04.002_bib50","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1111\/imj.13176","article-title":"Eosinophilic myocarditis: characteristics, diagnostics and outcomes of a rare condition","volume":"46","author":"Wang","year":"2016","journal-title":"Intern Med J"},{"key":"10.1016\/j.amjms.2017.04.002_bib51","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12872-015-0003-7","article-title":"A case report of eosinophilic myocarditis and a review of the relevant literature","volume":"15","author":"Li","year":"2016","journal-title":"BMC Cardiovasc Disord"},{"issue":"2","key":"10.1016\/j.amjms.2017.04.002_bib52","doi-asserted-by":"crossref","first-page":"123","DOI":"10.5415\/apallergy.2015.5.2.123","article-title":"Eosinophilic myocarditis: case series and literature review","volume":"5","author":"Sohn","year":"2016","journal-title":"Asia Pac Allergy"},{"issue":"17","key":"10.1016\/j.amjms.2017.04.002_bib53","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/MD.0000000000000088","article-title":"The lymphoid variant of hypereosinophilic syndrome: study of 21 patients with CD3-CD4+ aberrant T-cell phenotype","volume":"93","author":"Lefevre","year":"2014","journal-title":"Medicine (Baltimore)"},{"issue":"6","key":"10.1016\/j.amjms.2017.04.002_bib54","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1136\/annrheumdis-2014-206605","article-title":"Rituximab for IgG4-related disease: a prospective, open-label trial","volume":"74","author":"Carruthers","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.amjms.2017.04.002_bib55","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.leukres.2011.09.026","article-title":"Use of pegylated interferon in hypereosinophilic syndrome","volume":"36","author":"Butterfield","year":"2012","journal-title":"Leuk Res"},{"issue":"1","key":"10.1016\/j.amjms.2017.04.002_bib56","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1159\/000085560","article-title":"Interferon treatment for hypereosinophilic syndromes and systemic mastocytosis","volume":"114","author":"Butterfield","year":"2005","journal-title":"Acta Haematol"},{"issue":"12","key":"10.1016\/j.amjms.2017.04.002_bib57","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1056\/NEJMoa070812","article-title":"Treatment of patients with the hypereosinophilic syndrome with mepolizumab","volume":"358","author":"Rothenberg","year":"2008","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.amjms.2017.04.002_bib58","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1158\/1078-0432.CCR-08-1302","article-title":"Alemtuzumab therapy for hypereosinophilic syndrome and chronic eosinophilic leukemia","volume":"15","author":"Verstovsek","year":"2009","journal-title":"Clin Cancer Res"},{"issue":"4","key":"10.1016\/j.amjms.2017.04.002_bib59","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/sj.bmt.1705437","article-title":"Allogeneic bone marrow transplantation for hypereosinophilic syndrome: long-term follow-up with eradication of FIP1L1-PDGFRA fusion transcript","volume":"38","author":"Halaburda","year":"2006","journal-title":"Bone Marrow Transplant"}],"container-title":["The American Journal of the Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962917302033?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962917302033?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T01:05:12Z","timestamp":1692752712000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002962917302033"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":59,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["S0002962917302033"],"URL":"https:\/\/doi.org\/10.1016\/j.amjms.2017.04.002","relation":{},"ISSN":["0002-9629"],"issn-type":[{"value":"0002-9629","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Eosinophilic Myocarditis","name":"articletitle","label":"Article Title"},{"value":"The American Journal of the Medical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjms.2017.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Southern Society for Clinical Investigation. Published by All rights reserved.","name":"copyright","label":"Copyright"}]}}